Cargando…
The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a serious public health issue globally, currently, the treatment of NAFLD lies still in the labyrinth. In the inchoate stage, the combinatorial application of food regimen and favorable gut microbiota (GM) are considered as an alternative ther...
Autores principales: | Oh, Ki-Kwang, Yoon, Sang-Jun, Lee, Su-Been, Lee, Sang Youn, Gupta, Haripriya, Ganesan, Raja, Sharma, Satya Priya, Won, Sung-Min, Jeong, Jin-Ju, Kim, Dong Joon, Suk, Ki-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111676/ https://www.ncbi.nlm.nih.gov/pubmed/37069607 http://dx.doi.org/10.1186/s12967-023-04122-6 |
Ejemplares similares
-
The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023) -
Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023) -
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
Stigma of Maize and Avena Sativa
por: Owen, W. G.
Publicado: (1881)